 Connection
Steven Abman to Pulmonary Surfactants
This is a "connection" page, showing publications Steven Abman has written about Pulmonary Surfactants.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.779 |
|
|
|
-
Mueller C, Shepherd EG, Kielt MJ, Conroy S, Jensen EA, Bamat NA, Panitch H, Levin J, Guaman Cuevas M, Truog W, Abman SH, Nelin LD. Surfactant treatment at birth in a contemporary cohort of preterm infants with bronchopulmonary dysplasia. J Perinatol. 2024 Dec; 44(12):1827-1831.
Score: 0.216
-
Kramer BW, Abman S, Daly M, Jobe AH, Niklas V. Insulin-like growth factor-1 replacement therapy after extremely premature birth: An opportunity to optimize lifelong lung health by preserving the natural sequence of lung development. Paediatr Respir Rev. 2023 Dec; 48:24-29.
Score: 0.199
-
Mandell E, Kinsella JP, Abman SH. Persistent pulmonary hypertension of the newborn. Pediatr Pulmonol. 2021 03; 56(3):661-669.
Score: 0.171
-
Abman SH, Kinsella JP. Surfactant use in the term neonate with hypoxemic respiratory failure. J Pediatr. 1998 Nov; 133(5):716-7.
Score: 0.145
-
Mandell EW, Kratimenos P, Abman SH, Steinhorn RH. Drugs for the Prevention and Treatment of Bronchopulmonary Dysplasia. Clin Perinatol. 2019 06; 46(2):291-310.
Score: 0.037
-
G?thberg S, Parker TA, Abman SH, Kinsella JP. High-frequency oscillatory ventilation and partial liquid ventilation after acute lung injury in premature lambs with respiratory distress syndrome. Crit Care Med. 2000 Jul; 28(7):2450-6.
Score: 0.010
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|